Xcout Intel
ADIPO THERAPEUTICS, LLC competitors & alternatives
The 12 closest competitors and alternatives to ADIPO THERAPEUTICS, LLC among biotechnology companies — ranked by similarity to what ADIPO THERAPEUTICS, LLC actually does, not by market-cap band.
Subscribe to see ADIPO THERAPEUTICS, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About ADIPO THERAPEUTICS, LLC
Adipo Therapeutics is a biotechnology company developing treatments for obesity and metabolic-related diseases. The company utilizes Notch-inhibiting nanoparticles to convert energy-storing white fat into energy-burning brown fat to increase energy expenditure and resting metabolic rate.
ADIPO THERAPEUTICS, LLC at a glance
ADIPO THERAPEUTICS, LLC is a biotechnology company headquartered in United States. Its most recent funding round, Seed, raised $1M in May 2025. Xcout tracks 12 named people at ADIPO THERAPEUTICS, LLC, including Karen Wurster (CEO).
ADIPO THERAPEUTICS, LLC leadership
- Karen WursterCEO
- Keith JohnsChief Operating Officer
- Tom GabbertFractional CFO
- HARDY THOMASChief Medical Officer
- Meng DengFounder and Chief Scientist
- Sumitra GhateSenior Vice President of Product Development and Global Regulatory Affairs
6 more named people on record for ADIPO THERAPEUTICS, LLC, with roles, board committees and tenure — see the full roster →
ADIPO THERAPEUTICS, LLC funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $1M | 4 named | |
| SEC Form D filing | $4.7M | — | |
| Seed | $2.8M | 5 named | |
| SEC Form D filing | $1.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 ADIPO THERAPEUTICS, LLC competitors
Ranked by semantic similarity — how close each company is to ADIPO THERAPEUTICS, LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
AdipoPharma is a French biotech company dedicated to understanding the role of adipocyte cells in diabetes, focusing on lipid biosynthesis and whole-body metabolic health.
Similar biotechnology company
Carmot Therapeutics, Inc. is a biopharmaceutical company headquartered in Berkeley, California, focused on discovering and developing innovative treatments for metabolic diseases and obesity.
Similar biotechnology company
Adocia is a clinical-stage biotechnology company that develops innovative formulations of proteins, peptides, and metabolic hormones. The company specializes in creating treatments for diabetes and obesity, as well as immunoprotective scaffolds for cell therapies.
Similar biotechnology company
Parabolica Therapeutics develops proprietary peptide conjugation technologies focused on obesity and other metabolic conditions. The company researches and advances therapeutic programs through its scientific approach.
Similar biotechnology company
Atrogi is a clinical-stage biotechnology company headquartered in Stockholm, Sweden, pioneering the development of novel treatments for metabolic disorders.
Similar biotechnology company
Inversago Pharma is a Canadian biotechnology company developing peripherally restricted CB1 receptor antagonists/inverse agonists for metabolic, fibrotic, and related diseases. Its drug-development programs are intended to serve patients with conditions such as obesity, metabolic syndrome, and diabetic kidney disease.
Similar biotechnology company
Syntis Bio, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, dedicated to revolutionizing oral therapies for obesity and metabolic diseases.
Similar biotechnology company
Metabolic Solutions Development Company is a private biotechnology and drug discovery company founded in 2006. The firm focuses on investigating novel molecular targets and developing therapeutics to treat diabetes, metabolic syndrome, and related conditions.
Similar biotechnology company
Nostopharma is a women-owned biopharmaceutical company that develops novel precision delivery therapies and molecular interventions for patients with bone and connective tissue disorders. The company focuses on repurposing existing Hedgehog pathway inhibitors to prevent the onset of symptoms, slow disease progression, and treat conditions such as heterotopic ossification.
Similar biotechnology company
Nodal Therapeutics, Inc. is a biotechnology company seeking seed investment and co-development partnerships for its therapeutic pipeline.
Biotech
Endsulin, Inc. is a biotechnology company developing a liver-directed gene therapy for Type 1 Diabetes. Its proprietary technology aims to re-engineer liver cells to restore the body's natural ability to produce and regulate insulin, eliminating the need for artificial insulin delivery methods.
Similar biotechnology company
Mitotherapeutix, LLC is a biotechnology company that develops small interfering RNA (siRNA) based therapeutics targeting difficult disease pathways. The company focuses on modulating mitochondrial metabolic activity by inhibiting a negative gene regulator to treat a wide array of diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of ADIPO THERAPEUTICS, LLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ADIPO THERAPEUTICS, LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →